Buy CL Stock At $80?
1. Colgate-Palmolive (CL) stock is down 12% this year. 2. The company anticipates only 2% organic sales growth for 2025.
1. Colgate-Palmolive (CL) stock is down 12% this year. 2. The company anticipates only 2% organic sales growth for 2025.
The persisting decline in stock price highlights investor concerns over sales growth. Historically, similar growth projections have led to further declines in stock performance.
The projected sales growth is critical for investors and can highly influence CL's stock performance. Given current market conditions, a lack of growth may deter investment.
The immediate focus is on sales performance, which is expected to impact sentiment quickly. A significant change in growth projections can lead to rapid adjustments in stock price.